TrialAntimicrobial agents and chemotherapy2026
Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.
Hyoung Jin Kang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.